• Dr. S.P.Subhashini
• Ms. Layana Mathew
• Ms. Simrat

Coagulopathy in association with thrombotic complications and perhaps even disseminated intravascular coagulation (DIC) have become the hallmark of severe acute respiratory syndrome coronavirus 2 infections. The current guidance with regard to prevention of thrombosis and management of coagulopathy and DIC recommends pharmacological thromboprophylaxis be given to all immobilized and severely ill patients with COVID-19 unless otherwise contraindicated. Exploring the associated coagulation disease will aid in the understanding of the pathophysiological mechanisms underlying severe COVID-19.

"Correlation between COVID 19 and Disseminated Intravascular Coagulation ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 5, page no.b367-b369, May-2021, Available :http://www.jetir.org/papers/JETIR2105176.pdf

"Correlation between COVID 19 and Disseminated Intravascular Coagulation ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 5, page no. ppb367-b369, May-2021, Available at : http://www.jetir.org/papers/JETIR2105176.pdf